SULT2B1
Basic information
Region (hg38): 19:48552172-48599425
Links
Phenotypes
GenCC
Source:
- ichthyosis, congenital, autosomal recessive 14 (Strong), mode of inheritance: AR
- lamellar ichthyosis (Supportive), mode of inheritance: AR
- ichthyosis, congenital, autosomal recessive 14 (Limited), mode of inheritance: AR
- ichthyosis, congenital, autosomal recessive 14 (Strong), mode of inheritance: AR
- ichthyosis, congenital, autosomal recessive 14 (Strong), mode of inheritance: AR
- ichthyosis, congenital, autosomal recessive 14 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ichthyosis, congenital, autosomal recessive 14 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 28575648 |
ClinVar
This is a list of variants' phenotypes submitted to
- Ichthyosis, congenital, autosomal recessive 14 (4 variants)
- Autosomal recessive congenital ichthyosis 2 (3 variants)
- Autosomal recessive congenital ichthyosis 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULT2B1 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | ||||
missense | 30 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 4 | 2 | 31 | 17 | 12 |
Highest pathogenic variant AF is 0.00000657039
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULT2B1 | protein_coding | protein_coding | ENST00000201586 | 7 | 47351 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.436 | 0.563 | 125738 | 0 | 7 | 125745 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.11 | 187 | 235 | 0.796 | 0.0000153 | 2367 |
Missense in Polyphen | 49 | 74.923 | 0.654 | 800 | ||
Synonymous | 0.132 | 99 | 101 | 0.983 | 0.00000741 | 685 |
Loss of Function | 2.74 | 3 | 14.1 | 0.213 | 5.99e-7 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000376 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000337 | 0.0000327 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Sulfates hydroxysteroids like DHEA. Isoform 1 preferentially sulfonates cholesterol, and isoform 2 avidly sulfonates pregnenolone but not cholesterol. Plays a role in epidermal cholesterol metabolism and in the regulation of epidermal proliferation and differentiation (PubMed:28575648). {ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:28575648, ECO:0000269|PubMed:9799594}.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);17-Beta Hydroxysteroid Dehydrogenase III Deficiency;Sulfate/Sulfite Metabolism;Sulfite oxidase deficiency;Androgen and Estrogen Metabolism;Aromatase deficiency;Sulfation Biotransformation Reaction;Metapathway biotransformation Phase I and II;Vitamin A and Carotenoid Metabolism;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;Cytosolic sulfonation of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.576
Intolerance Scores
- loftool
- 0.0652
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.36
Haploinsufficiency Scores
- pHI
- 0.241
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sult2b1
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sulfate assimilation;steroid metabolic process;cholesterol metabolic process;negative regulation of cell population proliferation;positive regulation of epidermal cell differentiation;3'-phosphoadenosine 5'-phosphosulfate metabolic process
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum;cytosol;intracellular membrane-bounded organelle;extracellular exosome
- Molecular function
- nucleic acid binding;alcohol sulfotransferase activity;protein binding;cholesterol binding;steroid sulfotransferase activity;steroid hormone binding